The Gut-Immune Axis in Dogs – How Gut Health Supports Immune Health

“The gut-immune axis represents the foundation of your dog’s disease resistance, with 70% of immune tissue residing in the gut. While we cannot eliminate all health threats, we can nourish the microbial ecosystem that educates immune cells and determines whether the body fights infections or develops allergies.”

Summary

Approximately 70% of a dog’s immune system resides in the gut, making gut microbiome health not merely related to digestion but the primary determinant of disease resistance, allergy susceptibility, and the body’s capacity to regulate inflammation throughout life. With approximately 70% of the immune system residing in the gut^1,2, this relationship influences virtually every aspect of disease resistance, from defending against pathogens to preventing allergic reactions and autoimmune conditions. This comprehensive guide explores the science underlying gut-immune communication, examines its profound implications for allergies, autoimmune disorders, and infection susceptibility, and provides evidence-based nutritional strategies for optimising your dog’s immune function through targeted gut health support.

At Bonza, the gut-immune axis is one of the eight gut-organ axes central to the “One Gut. Whole Dog.” philosophy, with Block formulated specifically to support the gut-immune-skin triangle through targeted prebiotics, postbiotics including TruPet™, and anti-inflammatory botanicals, and Biotics delivering the complete Biotics Triad to address the gut foundation of immune health.

Key Takeaways

• Approximately 70% of the immune system resides in the gut, housed within gut-associated lymphoid tissue (GALT), making gut health inseparable from immune function and disease resistance.^1,2
• The gut microbiome actively educates and programmes the immune system, influencing the development of immune tolerance versus reactivity from early life onwards.^3,4
• Short-chain fatty acids (SCFAs) produced by beneficial gut bacteria are essential immunomodulators, promoting regulatory T cell development and reducing excessive inflammatory responses.^5,6
• Gut dysbiosis, an imbalance in intestinal microbial populations, is consistently associated with allergies, autoimmune conditions, and increased susceptibility to infections in dogs.^7,8,9
• The gut barrier serves as the body’s largest interface with the external environment, and its integrity directly determines whether the immune system encounters friend or foe.
• Dogs with allergies, including atopic dermatitis and food sensitivities, consistently show altered gut microbiome compositions that precede and contribute to immune dysfunction.^10,11
• Prebiotics, probiotics, and postbiotics can modulate immune function by supporting beneficial bacterial populations and delivering immunoregulatory metabolites directly.^12,13
• Essential nutrients including zinc, vitamin E, vitamin C, and omega-3 fatty acids support both gut barrier integrity and immune cell function, addressing the axis at multiple levels.
• A comprehensive nutritional approach combining gut microbiome support with immune-supporting nutrients offers the most effective strategy for optimising disease resistance and managing immune-related conditions.

In This Guide

• Why the Gut Is the Foundation of Canine Immune Health
• How the Gut-Immune Axis Shapes Your Dog’s Disease Resistance
• How the Gut Barrier Determines What the Immune System Encounters
• How Gut Dysbiosis Drives Allergic Disease in Dogs
• How Gut Health Influences Autoimmune Disease in Dogs
• How Gut Health Determines Your Dog’s Resistance to Infection
• Nutritional Modulation of the Gut-Immune Axis
• Evidence-Based Steps to Support Your Dog’s Gut-Immune Axis
• Supporting Your Dog’s Gut-Immune Axis: The Bonza Approach
• Frequently Asked Questions: Gut-Immune Axis in Dogs
• Conclusion:
• References
• Editorial Information

Why the Gut Is the Foundation of Canine Immune Health

When we think about immune health in dogs, we typically imagine white blood cells patrolling the bloodstream, ready to attack invaders. Yet this picture misses the most important truth about canine immunity: the vast majority of immune activity occurs not in the blood, but in the gut. The gastrointestinal tract is home to approximately 70% of the body’s immune tissue^1,2, making it the primary organ of immune surveillance and regulation. This concentration of immune tissue exists because the gut faces an extraordinary challenge, it must remain open to absorb nutrients whilst simultaneously defending against the constant threat of pathogens, toxins, and harmful antigens present in food and the environment.

The gut-immune axis describes the intricate bidirectional communication between the gastrointestinal system and the immune system. This isn’t simply about the gut hosting immune cells; it’s about a dynamic, ongoing conversation that shapes how the entire immune system develops, responds to threats, and maintains balance. The gut microbiome, the trillions of bacteria, fungi, and other microorganisms inhabiting the intestinal tract, plays a central role in this communication, producing metabolites that directly influence immune cell behaviour and educating the immune system about what should trigger a response and what should be tolerated^3,4.

Understanding this axis has profound implications for managing virtually every immune-related condition in dogs. Whether your dog suffers from allergies, recurring infections, autoimmune disease, or you simply want to support their immune resilience, the answer increasingly points toward gut health. This guide will explore the science behind gut-immune communication, examine how disruption of this axis contributes to disease, and provide evidence-based strategies for supporting your dog’s immune function through targeted gut health nutrition.

How the Gut-Immune Axis Shapes Your Dog’s Disease Resistance

The gut-immune axis is the bidirectional communication system between the gastrointestinal tract and the immune system, through which the gut microbiome directly shapes immune development, inflammatory thresholds, and disease resistance.

The gastrointestinal tract developed sophisticated immune mechanisms because it represents the body’s largest surface area exposed to the external environment. In dogs, this intestinal surface area, when flattened, would cover approximately the size of a small room, far exceeding the skin’s exposure.

Every day, this surface encounters food antigens, environmental particles, and countless microorganisms, some beneficial, some harmful. The immune system must make millions of split-second decisions about what to attack and what to allow, and the consequences of getting these decisions wrong are significant: overreact to food proteins and allergies develop; underreact to pathogens and infections flourish³.

The Gut: Headquarters of the Immune System

The gut-associated lymphoid tissue (GALT) comprises the most extensive collection of immune tissue in the body^1,2. This isn’t simply immune cells scattered throughout the intestinal lining, it’s a highly organised system with distinct structures performing specific functions:

• Peyer’s patches: These organised lymphoid structures in the small intestine serve as immune sensing stations. They sample antigens from the gut lumen through specialised M cells, presenting them to immune cells to generate appropriate responses, either tolerance to harmless substances or activation against threats.
• Mesenteric lymph nodes: The largest lymph nodes in the body, these process antigens captured from the gut and coordinate systemic immune responses. Decisions made here influence immunity throughout the body.
• Lamina propria: This layer beneath the intestinal epithelium houses enormous numbers of immune cells including plasma cells, macrophages, dendritic cells, and T lymphocytes in various states of activation and regulation.
• Intraepithelial lymphocytes (IELs): These T cells reside within the epithelial layer itself, providing first-line immune surveillance at the very interface between the body and the gut contents.
• Secretory IgA: The predominant antibody at mucosal surfaces, IgA is produced in massive quantities by plasma cells in the gut. Unlike other antibodies that trigger inflammation, IgA typically provides ‘immune exclusion’, binding to antigens and preventing their contact with the epithelium without causing inflammatory damage.

How the Microbiome Programmes Immunity

The gut microbiome doesn’t simply coexist with the immune system, it actively shapes its development and function throughout life^3,4. Research consistently demonstrates that the gut microbiota plays critical roles in educating immune cells, determining inflammatory thresholds, and establishing the balance between immune activation and tolerance. This programming begins in puppyhood, when early microbial colonisation patterns establish immune trajectories that persist into adulthood, but the microbiome continues to influence immune function throughout a dog’s life. The implications are profound: by supporting healthy microbiome composition, we can influence immune function at its foundations.

The Waltham catalogue identified 240 core bacterial species that account for over 80% of the healthy canine gut microbiome. ²¹ Every one of these species interacts with the immune system, through direct contact with gut-associated lymphoid tissue, through the metabolites they produce, and through the signals they send throughout the body. The researchers noted that the gut microbiome contributes to “essential host metabolic function, immune system education, and pathogen protection.” This isn’t passive coexistence; it’s active training. From puppyhood onwards, gut bacteria teach the immune system what’s friend and what’s foe. ²¹

One of the microbiome’s most crucial immune functions involves training the immune system to distinguish between harmful pathogens requiring aggressive responses and harmless antigens (like food proteins) requiring tolerance. When this education fails, often due to dysbiosis or insufficient microbial diversity, the immune system may attack harmless substances, leading to food allergies and food sensitivities, or conversely, fail to adequately respond to genuine threats, increasing infection susceptibility^7,8.

Among the study’s most reassuring findings: all 89 newly discovered bacterial species showed no known virulence factors. ²¹ These are commensal organisms, bacteria that have evolved alongside dogs to provide mutual benefit rather than cause disease. This distinction matters because it reinforces that a healthy microbiome is defined not just by the absence of pathogens, but by the presence of beneficial species performing essential functions. The 34 novel butyrate-producing species discovered, for example, contribute nearly 25% of the healthy microbiome’s abundance. Losing these populations doesn’t just create a vacuum, it removes active protection. ²¹

SCFAs: The Chemical Messengers of Immune Regulation

Short-chain fatty acids represent the primary language through which gut bacteria communicate with the immune system. When beneficial bacteria ferment dietary fibre, they produce SCFAs, primarily acetate, propionate, and butyrate, that exert profound immunomodulatory effects^5,6,14:

• Acetate: The most abundant SCFA, acetate supports immune cell metabolism and contributes to the maintenance of gut barrier integrity.
• Propionate: Influences immune cell development and function, with particular effects on dendritic cells and macrophages that shape immune responses.
• Butyrate: Perhaps the most immunologically significant SCFA, butyrate serves as the primary energy source for colonocytes whilst promoting regulatory T cell development, inhibiting inflammatory cytokine production, and maintaining gut barrier integrity. Decreased butyrate-producing bacteria are consistently observed in dogs with inflammatory bowel disease and other immune-related conditions.

Short-chain fatty acids, particularly butyrate, are potent immune modulators. They support the integrity of the gut barrier (preventing “leaky gut”), regulate inflammatory responses, and help maintain tolerance to harmless antigens while preserving vigilance against genuine threats. The Waltham study found that 37.5% of canine gut species possess butyrate-producing capacity, a figure that rises to 45.6% when measured by abundance. This suggests the healthy canine microbiome is architecturally designed for robust SCFA production, with immune support as a core function. ²¹

Through these metabolites, the microbiome continuously influences immune cell behaviour, promoting regulatory T cells that prevent excessive inflammation, modulating cytokine production, and maintaining the delicate balance between immune readiness and tolerance. When SCFA production decreases, whether due to dysbiosis, inadequate dietary fibre, or antibiotic use, immune regulation suffers, often manifesting as increased inflammation, heightened allergic responses, or impaired pathogen defence^5,6.

How the Gut Barrier Determines What the Immune System Encounters

The gut barrier represents far more than a physical wall, it’s a sophisticated, selectively permeable interface that determines what enters the body and what triggers immune responses. This barrier consists of multiple layers: the mucus layer that provides a first line of defence, the single layer of epithelial cells joined by tight junctions, and the underlying immune tissue. When functioning properly, this barrier allows nutrient absorption whilst excluding bacteria, toxins, and large antigenic molecules. When compromised, the consequences for immune function are significant and far-reaching.

Intestinal Permeability and Immune Activation

The concept of ‘leaky gut’, more accurately termed increased intestinal permeability, has moved from controversial hypothesis to established science. Research now confirms that various factors can compromise tight junction integrity, allowing substances that should remain in the gut lumen to contact the underlying immune tissue. These substances include bacterial components (particularly lipopolysaccharide/LPS from gram-negative bacteria), undigested food proteins, and other antigens that trigger immune activation when they breach the barrier.

In dogs, increased intestinal permeability has been documented in inflammatory bowel disease, food allergies, stress states, and following certain infections or antibiotic treatments^8,15. Once the barrier is compromised, a vicious cycle can develop: immune activation causes inflammation, which further damages the barrier, allowing more antigens to penetrate and perpetuating the inflammatory response. Breaking this cycle requires addressing both the barrier dysfunction and the underlying causes.

Endotoxaemia and Systemic Inflammation

When gut barrier integrity fails, one of the most significant consequences is the translocation of bacterial lipopolysaccharide (LPS) into the bloodstream, a condition termed metabolic endotoxemia. Even low levels of circulating LPS trigger systemic inflammatory responses through activation of toll-like receptor 4 (TLR4) on immune cells throughout the body. This chronic, low-grade inflammation has been implicated in numerous conditions affecting dogs, from allergies and skin problems to metabolic dysfunction and accelerated ageing.

The implications for immune function are substantial. Chronic LPS exposure can lead to immune dysregulation, with the system becoming simultaneously overactive (producing excessive inflammation) and underactive (with impaired pathogen defence due to immune exhaustion). Dogs with higher endotoxin levels often show increased susceptibility to infections whilst also displaying heightened inflammatory responses to normally harmless stimuli, an apparent paradox explained by the complex effects of chronic immune activation¹⁵.

Which Nutrients Maintain Gut Barrier Integrity

Maintaining gut barrier function is essential for proper immune regulation. Several nutritional factors have demonstrated barrier-supporting effects:

• L-glutamine: The primary fuel source for enterocytes (intestinal lining cells), glutamine supports barrier integrity by maintaining tight junction proteins and promoting epithelial cell renewal. Supplementation has shown benefit in various states of intestinal stress.
• Zinc: Essential for tight junction maintenance and epithelial repair. Zinc deficiency consistently impairs barrier function, whilst supplementation supports its restoration.
• Butyrate and butyrate-promoting nutrition: Beyond its immunomodulatory effects, butyrate directly supports colonocyte health and barrier function. Dietary approaches that increase butyrate production, including adequate fibre and prebiotic intake, support barrier integrity.
• Omega-3 fatty acids: EPA and DHA help resolve inflammation that damages barrier integrity whilst supporting the lipid components of epithelial cell membranes.
• Clinoptilolite: This natural zeolite mineral binds bacterial endotoxins in the gut lumen, preventing their translocation even when barrier function is compromised. This provides a safety net whilst other interventions address underlying barrier dysfunction.

How Gut Dysbiosis Drives Allergic Disease in Dogs

Gut dysbiosis drives allergic disease in dogs by disrupting the microbiome-immune education processes that establish tolerance to harmless antigens, with altered microbial composition consistently documented in allergic dogs before clinical symptoms appear.

Allergic disease in dogs has reached epidemic proportions, with estimates suggesting that canine atopic dermatitis alone affects up to 10-15% of the dog population¹⁰. Whilst genetics plays a role in allergic susceptibility, the gut-immune axis increasingly appears central to both the development and management of allergic conditions. Research consistently finds alterations in gut microbiome composition in allergic dogs, with these changes often preceding clinical symptoms, suggesting causation rather than mere correlation.

Why Dogs with Atopic Dermatitis Show Altered Gut Microbiome Patterns

Dogs with atopic dermatitis consistently show significantly reduced gut microbial diversity and altered SCFA production compared to healthy dogs, with these microbiome differences often preceding clinical skin symptoms.

Canine atopic dermatitis (CAD) provides a compelling example of gut-immune-skin axis dysfunction. Multiple studies have now demonstrated significant differences in the gut microbiome composition between atopic and healthy dogs^10,11,16. Research has found that dogs with atopic dermatitis show significantly lower gut microbial diversity compared to healthy dogs, with reduced populations of beneficial bacteria and altered SCFA production. The gut-skin axis, a recognised communication pathway between intestinal and skin immune systems, helps explain how gut dysbiosis contributes to skin inflammation and allergic responses.

Clinical signs of CAD, including chronic pruritus, recurrent ear infections, paw licking, and secondary skin infections, represent just the visible manifestation of deeper immune dysregulation. Affected dogs often show elevated IgE levels, T-helper cell imbalances favouring Th2 responses, and impaired regulatory T cell function. Emerging evidence suggests that supporting gut health may complement conventional CAD management by addressing some of these underlying immune imbalances.

For practical application of gut-immune support in allergic dogs, see our guide to natural antihistamines

How the Gut-Immune Axis Drives Food Allergies and Adverse Reactions

Whilst true IgE-mediated food allergies are relatively uncommon in dogs, adverse food reactions, encompassing both allergies and intolerances, affect significant numbers. The gut-immune axis plays a central role: food antigens are processed by the gut immune system, which must decide whether to mount a response or establish tolerance. When tolerance mechanisms fail, otherwise harmless food proteins trigger immune activation, manifesting as gastrointestinal signs, skin problems, or both.

Interestingly, increased intestinal permeability may contribute to food sensitivities by allowing larger, more antigenic food molecules to contact the immune system before adequate digestion has occurred. This creates a scenario where multiple food proteins trigger reactions, the common pattern of dogs becoming ‘allergic to everything’ likely reflects barrier dysfunction rather than true sensitisation to numerous proteins. Supporting barrier integrity alongside appropriate dietary management may improve outcomes in these challenging cases.

Nutritional Approaches for Managing Allergies Through the Gut-Immune Axis

Addressing allergies through the gut-immune axis involves several complementary approaches:

• Microbiome support: Probiotics, prebiotics, and postbiotics can help restore microbial diversity and improve SCFA production, potentially supporting the regulatory immune mechanisms that maintain tolerance.
• Barrier support: L-glutamine, zinc, and other barrier-supporting nutrients help reduce inappropriate antigen exposure that perpetuates allergic responses.
• Anti-inflammatory nutrients: Omega-3 fatty acids (EPA and DHA), curcumin, and other natural anti-inflammatories can help modulate the inflammatory component of allergic responses.
• Antioxidant support: Vitamins E and C, plus plant-derived antioxidants, protect tissues from oxidative damage during inflammatory responses.
• Novel or limited antigen diets: Alongside gut support, feeding novel protein sources or hydrolysed diets reduces immediate antigenic burden whilst allowing gut healing.

How Gut Health Influences Autoimmune Disease in Dogs

Gut dysbiosis is a key environmental modifier of autoimmune risk in dogs, with research consistently identifying reduced microbial diversity, impaired SCFA production, and compromised barrier function in animals with immune-mediated conditions.

Autoimmune diseases occur when the immune system loses its ability to distinguish self from non-self, attacking the body’s own tissues. Whilst genetic predisposition influences autoimmune risk, the gut-immune axis increasingly appears as a critical environmental modifier, either protecting against or promoting autoimmune development depending on its state^15,17.

Dogs suffer from numerous autoimmune conditions including immune-mediated haemolytic anaemia (IMHA), immune-mediated thrombocytopenia (IMT), immune-mediated polyarthritis (IMPA), inflammatory bowel disease (IBD), and various lupus variants.

The Mechanisms Linking Gut Dysbiosis to Autoimmune Disease

Research has identified several mechanisms linking gut health to autoimmune disease. Dogs with IBD, arguably the most clearly gut-associated autoimmune condition, consistently show significant dysbiosis with reduced microbial diversity, decreased populations of beneficial bacteria (particularly Faecalibacterium and other SCFA-producers), and increased Proteobacteria including potentially harmful Enterobacteriaceae^7,8,17. These changes aren’t simply consequences of inflammation, they appear to actively drive disease progression through reduced SCFA production, impaired regulatory T cell development, and compromised barrier function allowing bacterial translocation.

Molecular mimicry provides another connection: when microbial antigens share structural similarities with host tissues, immune responses generated against microbes may cross-react with self-tissues. Additionally, increased intestinal permeability allows microbial components to enter systemic circulation, potentially triggering or exacerbating autoimmune responses in susceptible individuals.

Nutritional Approaches That Complement Autoimmune Medical Management

Whilst autoimmune conditions typically require immunosuppressive therapy, nutritional support for the gut-immune axis may complement medical management:

• Veterinary partnership: Any nutritional interventions should complement, not replace, appropriate medical care. Discuss supplements with your veterinarian, particularly regarding interactions with immunosuppressive medications.
• Immune modulation vs. stimulation: Focus on nutrients that modulate rather than simply stimulate the immune system. Omega-3 fatty acids, for instance, promote resolution of inflammation rather than immune activation.
• Barrier restoration: Supporting gut barrier integrity may help reduce microbial translocation and the ongoing immune stimulation it causes.
• Antioxidant protection: Both the disease process and treatments like corticosteroids increase oxidative stress. Adequate antioxidant intake supports tissue protection.

How Gut Health Determines Your Dog’s Resistance to Infection

Gut microbiome composition is a primary determinant of immune resilience in dogs, governing pathogen recognition speed, colonisation resistance, and the capacity to mount effective antimicrobial responses.

Some dogs seem to catch every illness that goes around, whilst others rarely become sick despite similar exposure. This variation in immune resilience reflects differences in immune competence, the ability to mount effective responses against pathogens. The gut-immune axis plays a fundamental role in determining immune resilience, from training immune cells to recognise threats to maintaining the readiness required for rapid responses.

Building Immune Resilience Through Gut Health

Research demonstrates that gut microbiome composition directly influences the ability to fight infections. Dogs with diverse, healthy microbiomes show enhanced immune surveillance, faster pathogen recognition, and more effective antimicrobial responses^3,4,13. Several mechanisms underlie these effects:

• Colonisation resistance: A healthy microbiome physically excludes pathogens through competition for nutrients and attachment sites, produces antimicrobial compounds, and maintains an environment (including appropriate pH and oxygen levels) unfavourable to many pathogens.
• Immune priming: Commensal bacteria continually stimulate low-level immune surveillance, keeping the immune system ‘on alert’ and ready to respond quickly when genuine threats appear.
• Nutrient provision: Gut bacteria produce vitamins and other nutrients that support immune cell function. Dysbiosis can create functional nutrient deficiencies even with adequate dietary intake.
• Regulatory balance: A well-functioning gut-immune axis maintains the balance between pro- and anti-inflammatory responses, ensuring effective pathogen elimination without excessive tissue damage.

Nutritional Modulation of the Gut-Immune Axis

Nutrition modulates the gut-immune axis through four converging mechanisms: shaping microbiome composition, providing substrates for the short-chain fatty acid production that regulates immune cell behaviour, maintaining the gut barrier that controls antigen exposure, and supplying the micronutrients essential for immune cell development and function. A comprehensive nutritional approach addresses all four simultaneously, producing a broader and more durable basis for immune support than any single-ingredient intervention.

Prebiotics: Feeding Beneficial Bacteria

Prebiotics support immune function by selectively feeding the bacteria responsible for producing immunomodulatory short-chain fatty acids and competing against pathogens for intestinal resources. By increasing populations of SCFA-producing and commensal organisms, prebiotics amplify the microbiome’s capacity to educate and regulate the immune system. The following prebiotic types have demonstrated benefits relevant to canine gut-immune health:

• Fructo-oligosaccharides (FOS): Derived from chicory root, FOS supports Bifidobacteria and Lactobacilli populations whilst promoting butyrate production through cross-feeding mechanisms, strengthening the SCFA supply that underpins regulatory T cell development.
• Mannan-oligosaccharides (MOS): Derived from yeast cell walls, MOS binds directly to pathogenic bacteria, preventing their attachment to intestinal surfaces, whilst simultaneously supporting beneficial bacteria growth — addressing both the competitive and selective dimensions of microbiome-driven immune modulation.
• Beta-glucans: These complex polysaccharides from yeast and fungi exert dual immune effects: prebiotic support for beneficial bacteria, and direct activation of innate immune cells through dectin-1 receptors, enhancing pathogen defence without promoting excessive inflammatory responses.
• Inulin: A longer-chain fructan fermented more slowly than FOS, inulin extends prebiotic activity throughout the colon and supports SCFA production across a broader region of the intestinal tract.

Probiotics and Postbiotics: Direct Microbial Support

Probiotics support immune function through direct interaction with gut-associated lymphoid tissue, competitive exclusion of pathogens, enhanced barrier function, and production of immunomodulatory metabolites including SCFAs.¹²’¹³’¹⁸ Postbiotics, beneficial compounds derived from probiotic fermentation, including metabolites and cell wall components, offer equivalent immunomodulatory effects with the additional advantage of superior stability and consistent dosing. The following strains and postbiotic ingredients have documented mechanistic support for canine gut-immune health:

Bacillus velezensis DSM15544 (Calsporin®): A spore-forming probiotic with exceptional gastric stability that reaches the intestines intact. Research supports its ability to strengthen beneficial bacterial populations whilst inhibiting pathogen colonisation, contributing to both colonisation resistance and immune education.

Lactobacillus helveticus HA-122: Produces antimicrobial compounds and has demonstrated immunomodulatory effects including enhancement of secretory IgA production — a key mucosal defence mechanism that provides immune exclusion at the gut surface without triggering inflammatory responses.

TruPet™ Postbiotic: A standalone postbiotic delivering immunomodulatory compounds with consistent, stable dosing, supporting immune regulation independently of live organism survival through the gastrointestinal tract.

Beyond these core formulation strains, additional well-researched probiotic species demonstrate benefits relevant to gut-immune axis support. The following strains have documented mechanistic evidence in canine or closely related mammalian research:

• Lactobacillus rhamnosus: Reduces the duration and severity of acute diarrhoea whilst enhancing intestinal barrier function through increased mucin production and tight junction protein expression, with documented relevance to gut-immune modulation.
• Lactobacillus acidophilus: Produces substantial quantities of lactic acid, creating conditions unfavourable for pathogenic bacteria, and supports immune modulation through reduced allergic responses and enhanced natural antimicrobial compound production within the gut environment.
• Lactobacillus plantarum: Survives gastric acidity reliably, produces bacteriocins that inhibit pathogenic species, and demonstrates benefits for intestinal permeability — directly relevant to preventing the bacterial translocation that drives chronic immune activation.
• Lactobacillus reuteri: Produces reuterin, a broad-spectrum antimicrobial effective against bacteria, fungi, and protozoa without significantly disrupting beneficial commensals, whilst also supporting healthy intestinal motility and B vitamin synthesis.
• Enterococcus faecium (SF68): Strains with documented safety profiles reduce stress-induced diarrhoea and pathogen colonisation through lactic acid and bacteriocin production, with natural bile salt resistance ensuring reliable gastrointestinal survival.
• Bifidobacterium animalis: Produces beneficial exopolysaccharides that enhance gut barrier function and demonstrates effectiveness in immune modulation relevant to the gut-immune axis.
• Bifidobacterium longum: Enhances immune modulation, reduces pathogen adhesion to intestinal epithelium, and produces metabolites that support signalling pathways relevant to systemic immune regulation.
• Bacillus coagulans: Combines spore-forming stability with lactic acid production, surviving processing and gastric transit reliably. Canine studies demonstrate support for healthy inflammatory responses relevant to multiple gut-organ axes.
• Saccharomyces boulardii: Survives antibiotic treatment unlike bacterial probiotics, demonstrating effectiveness against enteric pathogens, enhancing secretory IgA production, and supporting barrier integrity during dysbiosis.

Research increasingly supports multi-strain formulations that provide complementary mechanisms across the various gut-immune communication pathways, rather than relying on any single organism.

Key Nutrients Required for Immune Cell Development and Function

Several micronutrients are essential for immune cell development, function, and repair, operating alongside microbiome modulation rather than through it. Deficiencies in any of these nutrients impair specific aspects of immune competence even when microbiome composition is otherwise healthy. The following micronutrients have the strongest evidence base for canine immune support:

• Zinc (glycinate form): Required for development and function of neutrophils, natural killer cells, and T lymphocytes, as well as antibody production and mucosal barrier integrity. Zinc deficiency impairs virtually every aspect of immune function; chelated forms such as zinc glycinate offer superior bioavailability compared to inorganic salts.
• Vitamin E (RRR-alpha-tocopherol): The natural form of vitamin E protects immune cell membranes from oxidative damage during inflammatory responses and supports T cell function.
• Vitamin C: Supports neutrophil activity, lymphocyte proliferation, and interferon production, contributing to both innate and adaptive immune responses.
• B vitamins: Essential for the energy metabolism required by rapidly dividing immune cells during active immune responses.
• L-glutamine: The primary fuel source for lymphocytes and macrophages, particularly during immune activation, as well as serving as the primary energy substrate for enterocytes maintaining barrier integrity.
• Taurine: An essential amino acid for dogs, taurine supports immune cell function and contributes to anti-inflammatory signalling.

Omega-3 Fatty Acids: Inflammation Resolution

EPA and DHA support immune regulation not by suppressing inflammation, but by actively promoting its resolution — the biological process through which inflammatory responses are appropriately terminated after threats have been eliminated. This distinction carries clinical significance: chronic unresolved inflammation is a primary driver of immune dysregulation, and omega-3 fatty acids address this mechanism directly rather than simply dampening immune activity. EPA and DHA also influence the composition of immune cell membranes, modulating receptor function and downstream signalling. Algal sources provide these essential omega-3s without the sustainability concerns or contaminant risks associated with fish oils.

Anti-Inflammatory Botanicals That Modulate Gut-Immune Signalling

Several plant-derived compounds modulate inflammatory signalling pathways relevant to gut-immune function by inhibiting specific enzymes and transcription factors involved in inflammatory cascades. These botanicals complement microbiome-level and nutrient-level support by addressing the inflammatory dimension of immune dysregulation downstream of the gut. The following botanicals have evidence supporting their relevance to canine gut-immune health:

• Curcumin with black pepper extract: Modulates multiple inflammatory pathways including NF-kB and COX enzymes. Black pepper extract (piperine) substantially enhances curcumin absorption and is required to achieve meaningful bioavailability.
• Boswellia serrata: Contains boswellic acids that inhibit 5-lipoxygenase, reducing leukotriene production relevant to both gut and systemic inflammatory responses.
• Ginger: Contains gingerols with anti-inflammatory properties particularly relevant to gastrointestinal inflammatory signalling.
• Green tea extract: Rich in catechins including EGCG, which modulates immune cell function and provides antioxidant protection at the gut mucosal surface.
• Spirulina: Contains phycocyanin and related compounds with both anti-inflammatory and immune-supporting properties, contributing to the antioxidant environment required for regulated immune function.

Evidence-Based Steps to Support Your Dog’s Gut-Immune Axis

Supporting your dog’s gut-immune axis requires a coordinated strategy that addresses microbiome composition, gut barrier integrity, and immune-essential nutrient provision together, rather than targeting any single aspect in isolation. The following steps translate the nutritional mechanisms described in the section above into practical daily action.

1. Build the diet around microbiome-supporting ingredients. Choose a nutritionally complete diet containing prebiotic fibres — FOS, MOS, beta-glucans, and inulin — that sustain diverse beneficial bacterial populations. Consistent microbiome support through the daily diet is the single most impactful ongoing contribution to gut-immune health. For the mechanistic basis of prebiotic and probiotic ingredient selection, see the Nutritional Modulation section above.
2. Add targeted biotics for immune-specific requirements. For dogs with active immune challenges — allergies, recurring infections, autoimmune conditions, or post-antibiotic recovery — a supplement combining prebiotics, probiotics, and postbiotics at therapeutic concentrations provides support that diet alone cannot reliably deliver. Calsporin® and TruPet™ are the formulation-grade probiotic and postbiotic ingredients with the strongest canine evidence base for this purpose.
3. Support gut barrier integrity proactively, not just reactively. Ensure adequate zinc provision in the diet or via supplementation year-round. During periods of elevated intestinal stress — illness, antibiotic use, or significant dietary transition — L-glutamine supplementation supports barrier repair demand. Consistent provision of dietary omega-3 fatty acids reduces the chronic inflammation that compromises barrier function over time.
4. Audit the diet for immune-essential micronutrient provision. Review the daily diet for adequate zinc, vitamin E, vitamin C, and B vitamin content. Deficiency in any one of these nutrients reduces immune competence independently of microbiome status. Where supplementation is needed, prioritise chelated mineral forms — particularly zinc glycinate — for superior bioavailability.
5. Use omega-3 fatty acids consistently for dogs with chronic inflammatory conditions. For dogs with allergies, autoimmune conditions, or persistent skin inflammation, consistent daily provision of EPA and DHA — preferably from algal sources — supports the resolution of inflammation rather than its suppression, addressing the underlying immune dysregulation rather than masking its effects.
6. Protect the microbiome from unnecessary disruption. Reserve antibiotics for confirmed bacterial infections where treatment is clinically necessary. Where antibiotics are prescribed, administer a compatible probiotic at least two to three hours apart from each dose. Continue probiotic support for a minimum of four to six weeks after completing the course, given the extended timeline of microbiome recovery documented in research.²⁰
7. Treat chronic stress as an immune management variable. Sustained cortisol exposure impairs both gut barrier function and immune competence. Environmental enrichment, consistent daily routines, and appropriate exercise levels support both systems and should be considered an active component of gut-immune management rather than optional lifestyle factors.
8. Match supplementation strategy to your dog’s specific immune profile. Dogs with allergies benefit most from a combined approach of barrier support, microbiome modulation, and anti-inflammatory botanical provision. Dogs prone to recurring infections benefit from colonisation resistance support and consistent immune priming through daily prebiotic and probiotic provision. Dogs with autoimmune conditions require immune-modulating rather than immune-stimulating approaches — omega-3 fatty acids, postbiotics, and antioxidant support — always implemented in partnership with veterinary medical management.

Supporting Your Dog’s Gut-Immune Axis: The Bonza Approach

Bonza Superfoods and Ancient Grains plant-based dog food and Biotics Bioactive Bites are formulated to address the gut-immune axis at both the microbial foundation and the barrier level, combining the complete Biotics Triad with gut barrier repair nutrients and anti-inflammatory botanicals.

Bonza’s “One Gut. Whole Dog.” philosophy recognises that immune resilience is built in the gut, not supplemented around it. The gut-immune axis is one of the eight gut-organ axes underpinning Bonza’s formulation framework, informing both Superfoods & Ancient Grains and the Bioactive Bites supplement range. The daily food provides foundational gut-immune axis support through Calsporin®, TruPet™ postbiotic, prebiotic chicory, yeast-derived MOS and beta-glucans, DHAgold® algae-derived omega-3, and the PhytoPlus® botanical blend, working together through the Biotics Triad to maintain the microbiome balance, SCFA production, and gut barrier integrity that healthy immune function depends on.

For dogs requiring targeted gut-immune axis support, Biotics Bioactive Bites is formulated specifically for this axis, combining the complete Biotics Triad at therapeutic concentrations, TruPet™ postbiotic (285mg), Calsporin® (4.5 × 10⁴ CFU), and Lactobacillus helveticus (2.7 × 10⁹ CFU), Fibrofos™ 60 (218mg) and Biolex® MB40 (278mg) alongside L-glutamine and zinc glycinate for gut barrier repair, clinoptilolite for endotoxin binding, and a concentrated anti-inflammatory botanical network of turmeric, Boswellia, and ginger. Used together with Superfoods & Ancient Grains, Biotics addresses the gut-immune axis at both ends simultaneously, from the microbial foundation of immune education to the barrier integrity that determines what the immune system encounters.

Frequently Asked Questions: Gut-Immune Axis in Dogs

Conclusion

The gut-immune axis represents one of the most important yet underappreciated aspects of canine health. Understanding that approximately 70% of the immune system resides in the gut, and that the gut microbiome actively programmes immune function, fundamentally changes how we approach immune health in dogs. Rather than viewing immune conditions as isolated problems requiring targeted treatments alone, we can now recognise the foundational role of gut health and address immune dysfunction at its roots.

For dogs struggling with allergies, the gut-immune connection offers new therapeutic avenues beyond allergen avoidance and symptom suppression. For those with autoimmune conditions, supporting gut health may complement medical management by addressing underlying immune dysregulation. For dogs with frequent infections, building immune resilience through microbiome support may reduce susceptibility. And for all dogs, maintaining a healthy gut-immune axis supports the balanced, responsive immunity that underlies long-term health.

The science continues to evolve, with new research regularly revealing additional connections between gut and immune health. What remains clear is that nutrition represents our most powerful tool for influencing this axis, through providing prebiotic fibres that feed beneficial bacteria, probiotics and postbiotics that directly support the microbiome, nutrients that maintain barrier integrity, and compounds that modulate inflammatory responses. A comprehensive approach addressing multiple aspects of gut-immune communication offers dogs the best opportunity for robust, balanced immune function throughout their lives.

References

1. Pilla R, Suchodolski JS. The Role of the Canine Gut Microbiome and Metabolome in Health and Gastrointestinal Disease. Frontiers in Veterinary Science. 2020;6:498. doi:10.3389/fvets.2019.00498
2. Tizard IR, Jones SW. The microbiota regulates immunity and immunologic diseases in dogs and cats. Veterinary Clinics of North America: Small Animal Practice. 2018;48(2):307-322. doi:10.1016/j.cvsm.2017.10.008
3. Deng P, Swanson KS. Gut microbiota of humans, dogs and cats: current knowledge and future opportunities and challenges. British Journal of Nutrition. 2015;113(S1):S6-S17. doi:10.1017/S0007114514002943
4. Barko PC, McMichael MA, Swanson KS, Williams DA. The Gastrointestinal Microbiome: A Review. Journal of Veterinary Internal Medicine. 2018;32(1):9-25. doi:10.1111/jvim.14875
5. Minamoto Y, Otoni CC, Steelman SM, et al. Alteration of the fecal microbiota and serum metabolite profiles in dogs with idiopathic inflammatory bowel disease. Gut Microbes. 2015;6(1):33-47. doi:10.1080/19490976.2014.997612
6. Tan J, McKenzie C, Potamitis M, Thorburn AN, Mackay CR, Macia L. The Role of Short-Chain Fatty Acids in Health and Disease. Advances in Immunology. 2014;121:91-119. doi:10.1016/B978-0-12-800100-4.00003-9
7. Vázquez-Baeza Y, Hyde ER, Suchodolski JS, Knight R. Dog and human inflammatory bowel disease rely on overlapping yet distinct dysbiosis networks. Nature Microbiology. 2016;1:16177. doi:10.1038/nmicrobiol.2016.177
8. Suchodolski JS, Dowd SE, Wilke V, Steiner JM, Jergens AE. 16S rRNA gene pyrosequencing reveals bacterial dysbiosis in the duodenum of dogs with idiopathic inflammatory bowel disease. PLoS ONE. 2012;7(6):e39333. doi:10.1371/journal.pone.0039333
9. Suchodolski JS, Markel ME, Garcia-Mazcorro JF, et al. The fecal microbiome in dogs with acute diarrhea and idiopathic inflammatory bowel disease. PLoS ONE. 2012;7(12):e51907. doi:10.1371/journal.pone.0051907
10. Thomsen M, Künstner A, Wohlers I, et al. A comprehensive analysis of gut and skin microbiota in canine atopic dermatitis in Shiba Inu dogs. Microbiome. 2023;11:232. doi:10.1186/s40168-023-01671-2
11. Song H, Mun SH, Han DW, et al. Probiotics ameliorate atopic dermatitis by modulating the dysbiosis of the gut microbiota in dogs. BMC Microbiology. 2025;25:228. doi:10.1186/s12866-025-03924-6
12. Rossi G, Pengo G, Caldin M, et al. Comparison of microbiological, histological, and immunomodulatory parameters in response to treatment with either combination therapy with prednisone and metronidazole or probiotic VSL#3 strains in dogs with idiopathic inflammatory bowel disease. PLoS ONE. 2014;9(4):e94699. doi:10.1371/journal.pone.0094699
13. Schmitz S, Suchodolski J. Understanding the canine intestinal microbiota and its modification by pro-, pre- and synbiotics – what is the evidence? Veterinary Medicine and Science. 2016;2(2):71-94. doi:10.1002/vms3.17
14. Minamoto Y, Minamoto T, Isaiah A, et al. Fecal short-chain fatty acid concentrations and dysbiosis in dogs with chronic enteropathy. Journal of Veterinary Internal Medicine. 2019;33(4):1608-1618. doi:10.1111/jvim.15520
15. Hullar MAJ, Lampe JW, Torok-Storb BJ, Harkey MA. The canine gut microbiome is associated with higher risk of gastric dilatation-volvulus and high risk genetic variants of the immune system. PLoS ONE. 2018;13(6):e0197686. doi:10.1371/journal.pone.0197686
16. Rodriguez-Campos S, Rostaher A, Zwickl L, et al. Impact of the early-life skin microbiota on the development of canine atopic dermatitis in a high-risk breed birth cohort. Scientific Reports. 2020;10:1044. doi:10.1038/s41598-020-57798-x
17. Jergens AE, Guard BC, Redfern A, et al. Microbiota-related changes in unconjugated fecal bile acids are associated with naturally occurring, insulin-dependent diabetes mellitus in dogs. Frontiers in Veterinary Science. 2019;6:199. doi:10.3389/fvets.2019.00199
18. Grzeskowiak Ł, Endo A, Beasley S, Salminen S. Microbiota and probiotics in canine and feline welfare. Anaerobe. 2015;34:14-23. doi:10.1016/j.anaerobe.2015.04.002
19. Guard BC, Mila H, Steiner JM, Mariani C, Suchodolski JS, Chastant-Maillard S. Characterization of the fecal microbiome during neonatal and early pediatric development in puppies. PLoS ONE. 2017;12(4):e0175718. doi:10.1371/journal.pone.0175718
20. Pilla R, Gaschen FP, Barr JW, et al. Effects of metronidazole on the fecal microbiome and metabolome in healthy dogs. Journal of Veterinary Internal Medicine. 2020;34(5):1853-1866. doi:10.1111/jvim.15871
21. Castillo-Fernandez JE, Waltham Petcare Science Institute, et al. Waltham catalogue for the canine gut microbiome: a complete taxonomic and functional catalogue of the canine gut microbiome through novel metagenomic based genome discovery. Microbiome. 2026;14(1):25. doi:10.1186/s40168-025-02265-w

Editorial Information

Published	16 January 2026
Last updated	April 2026:
Last reviewed	April 2026
Next review due	April 2027
Author	Glendon Lloyd, Dip. Canine Nutrition (Dist.), Dip. Canine Nutrigenomics (Dist.)
Medical disclaimer	This article is for informational purposes only and does not constitute veterinary advice. Always consult a qualified veterinarian before making changes to your dog’s diet or supplement regimen.